180 related articles for article (PubMed ID: 12185047)
1. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic mammography and sonography: concordance of the breast imaging reporting assessments and final clinical outcome].
Lorenzen J; Wedel AK; Lisboa BW; Löning T; Adam G
Rofo; 2005 Nov; 177(11):1545-51. PubMed ID: 16302136
[TBL] [Abstract][Full Text] [Related]
3. BI-RADS categorization as a predictor of malignancy.
Orel SG; Kay N; Reynolds C; Sullivan DC
Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
[TBL] [Abstract][Full Text] [Related]
4. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up.
Masroor I
J Coll Physicians Surg Pak; 2008 Apr; 18(4):209-12. PubMed ID: 18474152
[TBL] [Abstract][Full Text] [Related]
6. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
8. Coding mammograms using the classification "probably benign finding--short interval follow-up suggested".
Caplan LS; Blackman D; Nadel M; Monticciolo DL
AJR Am J Roentgenol; 1999 Feb; 172(2):339-42. PubMed ID: 9930778
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
[TBL] [Abstract][Full Text] [Related]
11. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
Wiratkapun C; Lertsithichai P; Wibulpholprasert B
J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
[TBL] [Abstract][Full Text] [Related]
12. Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer.
Helvie MA; Bailey JE; Roubidoux MA; Pass HA; Chang AE; Pierce LJ; Wilkins EG
Radiology; 2002 Jul; 224(1):211-6. PubMed ID: 12091685
[TBL] [Abstract][Full Text] [Related]
13. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography.
Kim EK; Ko KH; Oh KK; Kwak JY; You JK; Kim MJ; Park BW
AJR Am J Roentgenol; 2008 May; 190(5):1209-15. PubMed ID: 18430833
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
16. Prediction of benignity or malignancy of a lesion using BI-RADS.
Masroor I
J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
[TBL] [Abstract][Full Text] [Related]
17. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
[TBL] [Abstract][Full Text] [Related]
18. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities.
Ball CG; Butchart M; MacFarlane JK
Can J Surg; 2002 Aug; 45(4):259-63. PubMed ID: 12174979
[TBL] [Abstract][Full Text] [Related]
19. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
[TBL] [Abstract][Full Text] [Related]
20. Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions.
Dragun AE; Jenrette JM; Ackerman SJ; Irshad A; Pope TL
Am J Clin Oncol; 2007 Dec; 30(6):574-9. PubMed ID: 18091050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
